Computer Science, asked by Aritra913, 3 months ago

Q1. Explain the application of Artificial Intelligence for COVID-19 vaccine rollout.

Q2. What are the advantages of Artificial Intelligence for COVID-19 vaccine rollout? (Write in points)

Answers

Answered by YakshPatel007
2

Answer:

1). Advanced technologies such as artificial intelligence, machine learning, and natural language processing have been deployed in the battle against Covid-19 since the pandemic’s earliest days. It started with the ability of AI to track the spread of the disease in order to limit the number of positive cases. It’s also been used to parse the billions of pieces of data and thousands of scientific papers on the topic needed to develop the vaccines that are about to be distributed. And now, AI and other digital tools are being deployed to manage complex supply chains for the vaccine, and to collect the immense amount of data needed to track any adverse effects individuals might have after receiving it.

2). The question of who should get access to COVID-19 vaccines first has varied from state to state, with some governments prioritizing those with high-risk conditions and others lowering the age of eligibility.

One South Dakota-based system, Sanford Health, is using a machine learning model to identify which individuals are at greatest risk of having severe COVID-19 outcomes – and applying the algorithm to eligible groups.

"With [those] 85,000 people what we can do is take a real-time picture that evolves over time, using computer learning to tell us what patients or what people in the Midwest get the sickest from COVID-19," said Sanford chief physician Dr. Jeremy Cauwels to Minnesota Public Radio.

Cauwels told MPR that he believes an artificial intelligence approach is more equitable than random choice for administering the vaccine.

Sanford isn't alone. Experts say AI has big potential to assist with the COVID-19 vaccine rollout.

"The pace and scale of the vaccine rollout is unprecedented, and we are seeing AI play a role," said Lori Jones, chief revenue officer and president for the provider market at Olive, an AI-as-a-service vendor.

Rather than using AI to identify at-risk patients, Jones noted its potential to promote efficiency within existing workflows.

"The biggest areas of focus for organizations that we’re working with have all related to managing the organization, scheduling, preregistration and communications activity around the testing and vaccines themselves, with additional automation activity to streamline patient communications and drive better vaccine efficacy by ensuring patients are aware, prepared and present to receive second doses," Jones explained.

"We’ve got an important mission ahead of us still, and if we can’t expand the capacity of organizations delivering the vaccines to take on more patients faster, then there is a very real risk that this process could take years, not months," she said.

Jones pointed to chatbots as a prime example of the way AI can be used in conjunction with other tools, specifically when it comes to patient engagement.

"AI-enabled digital call centers are helping organizations manage the significant level of interest in key vaccine information," she said. "FAQs can be converted into chatbots to refresh the available information to be COVID-19-specific."

Similar questions